Nuclear Medicine: Page 345

EBRT/brachytherapy prostate cancer combo shows long-term effectiveness

By Jonathan S. Batchelor

The pairing of external-beam radiation therapy (EBRT) followed by brachytherapy has shown strong results in long-term relapse-free survival rates in prostate cancer patients, according to researchers of a new study. They found that low- and intermediate-risk patients experienced high disease-free survival rates with this treatment.

January 24, 2007

Study: PET posts double-digit gains in Western Europe

By AuntMinnie.com staff writers

A study by healthcare consultants Medical Options of London estimated that 491,000 patient studies will be performed using PET in Western Europe in 2006.

January 21, 2007

Bayer Schering to develop PET brain imaging agents

By AuntMinnie.com staff writers

Berlin-based Bayer Schering Pharma (formerly Schering) has signed a license and option agreement with two Japanese companies and the National Institute of Radiological Sciences (NIRS) in Japan to develop imaging compounds for detecting neurodegenerative diseases such as Alzheimer's and Parkinson's diseases.

January 18, 2007

IBA expands production capacity

By AuntMinnie.com staff writers

Nuclear medicine products firm Ion Beam Applications (IBA) has launched an expansion program to meet the demand for its proton therapy systems.

January 18, 2007

New tracer shows promise for PET/CT prostate imaging

By Jonathan S. Batchelor

One in six men in the U.S. will get prostate cancer during his lifetime, according to recent data. Unfortunately, conventional imaging techniques are limited for detecting, staging, and restaging this carcinoma. But a study by scientists at Emory University in Atlanta and researchers in Japan finds that a new radiotracer shows promse in evaluating and staging prostate cancer.

January 17, 2007

2007 01 17 17 19 14 706

IsoRay adds cesium-131 sites

By AuntMinnie.com staff writers

Medical isotope developer IsoRay Medical has increased the number of sites either producing or getting ready to produce cesium-131.

January 16, 2007

Fuji renames Daiichi subsidiary

By AuntMinnie.com staff writers

Japanese film and technology company Fujifilm has applied its corporate branding to its recently acquired Daiichi Radioisotope Laboratories (DRL) subsidiary, with the division to be known as Fujifilm RI Pharma, effective April 1.

January 16, 2007

Neoprobe gets FDA nod for more Lymphoseek trials

By AuntMinnie.com staff writers

Gamma camera probe developer Neoprobe has received authorization from the U.S. Food and Drug Administration (FDA) to begin patient enrollment in two phase I clinical studies for its Lymphoseek targeting agent.

January 16, 2007

Nuclear pharmacy operators merge to form Triad Isotopes

By AuntMinnie.com staff writers

Three nuclear pharmacy operators have merged operations to form a new company, Triad Isotopes.

January 16, 2007

Digirad updates 2006 guidance

By AuntMinnie.com staff writers

Nuclear medicine vendor Digirad yesterday updated its previous financial guidance for 2006 and provided initial guidance for 2007.

January 11, 2007

SPECT/CT enhances octreotide imaging

By Jonathan S. Batchelor

Indium-111-labeled octreotide imaging has shown greater accuracy than CT or MRI scans in detecting somatostatin receptor-positive neuroendocrine tumors. But anatomic localization of these tumors solely based on octreotide scans is problematic, so these procedures are usually performed with CT or MRI. A recent study suggests that SPECT/CT in octreotide imaging can provide important diagnostic information to clinicians that is unavailable with planar whole-body scans.

January 11, 2007

IBA nets U.S. proton therapy order

By AuntMinnie.com staff writers

Belgian nuclear medicine products firm Ion Beam Applications has been selected by ProCure Treatment Centers to build a four-room proton therapy center in Oklahoma City.

January 7, 2007

Page 345 of 440